Saturday, November 7, 2020

Pharma Reviews: Biocon Biologics gets Rs 1125 cr capital infusion from Goldman Sachs

The company is confident of achieving aspiration of serving 5 million ... be a major global player in this dynamic segment of the pharmaceutical industry, ... making it the only company from India to enable affordable access to three ...
Read more: Biocon Biologics gets Rs 1125 cr capital infusion from Goldman Sachs